Toboroz
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
NCT07903415· 1. fázis· Pfizer· Forrás
Toboroz
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
NCT07683754· 3. fázis· Daiichi Sankyo· Forrás
Contact: Principal Investigator
Toboroz
JUR-003 in Adult Patients With Metastatic Prostate Cancer
NCT07824349· 1. fázis· Juri Biosciences, Inc.· Forrás
Contact: Lisa Knapp
Toboroz
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
NCT07578649· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
NCT07843940· 1/2. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
NCT07520006· 1/2. fázis· Nurix Therapeutics, Inc.· Forrás
Toboroz
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
NCT07778498· 1/2. fázis· Phrontline Biopharma· Forrás
Contact: Hamilton, Erika
Toboroz
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
NCT07701941· 1/2. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
NCT07637578· 2. fázis· SCRI Development Innovations, LLC· Forrás
Contact: Hans Lee, MD (principal investigator)
Toboroz
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
NCT07516093· 3. fázis· Nurix Therapeutics, Inc.· Forrás
Még nem toboroz
Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
NCT07707674· 1. fázis· Evopoint Biosciences Inc.· Forrás
Contact: New Patient Referrals
Toboroz
DBC-664 in Adult Patients With Solid Tumors
NCT07705035· 1. fázis· Duboce Biopharmaceuticals, Inc.· Forrás
Contact: Lisa Knapp
Toboroz
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328· 1. fázis· Eli Lilly and Company· Forrás
Toboroz
A Phase 1 Study of the Safety and Tolerability of CTX-10726
NCT07419841· 1. fázis· Compass Therapeutics· Forrás
Contact: Meredith Pelster, MD
Toboroz
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
NCT07542704· 1. fázis· Kumquat Biosciences Inc.· Forrás
Contact: Deepak Bhamidipati
Toboroz
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
NCT07566156· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás
Toboroz
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Contact: Communication Center
Toboroz
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
NCT07558733· 1/2. fázis· Faeth Therapeutics· Forrás
Contact: Medical Monitor
Toboroz
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995· 3. fázis· BioNTech SE· Forrás
Toboroz
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
NCT07545811· 1. fázis· Janux Therapeutics· Forrás
Contact: Janux Therapeutics, MD
Toboroz
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
NCT07524855· 1. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
NCT07519655· 1. fázis· Pfizer· Forrás
Toboroz
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Melissa Johnson, Site 0240
Toboroz
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
NCT07221149· 2/3. fázis· Bristol-Myers Squibb· Forrás
Contact: Meredith Pelster, Site 0417
Toboroz
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
NCT07421700· 1/2. fázis· Pfizer· Forrás
Toboroz
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
NCT07491497· 1/2. fázis· TRIANA Biomedicines, Inc.· Forrás
Contact: AskSarah
Toboroz
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445· 3. fázis· Revolution Medicines, Inc.· Forrás
Contact: Revolution Medicines Study Director
Toboroz
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
NCT07503808· 1. fázis· IDEAYA Biosciences· Forrás
Contact: Deepak Bhamidipati
Toboroz
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
NCT07227415· 1/2. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
NCT07266441· 2. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT07325136· 1/2. fázis· Bristol-Myers Squibb· Forrás
Contact: Melissa Johnson, Site 0006
Toboroz
Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190· 3. fázis· IDEAYA Biosciences· Forrás
Contact: Meredith McKean, MD Principal Investigator
Toboroz
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
NCT07195682· 1. fázis· Bristol-Myers Squibb· Forrás
Contact: Benjamin Garmezy, Site 0026
Toboroz
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
NCT07188558· 3. fázis· Lyell Immunopharma, Inc.· Forrás
Contact: James Dean, MD, PhD
Toboroz
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
NCT07195916· 1. fázis· Incyte Corporation· Forrás
Toboroz
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás
Contact: Meredith Pelster, Site 0570
Toboroz
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232· 3. fázis· Revolution Medicines, Inc.· Forrás
Contact: Revolution Medicines Study Director
Toboroz
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380· 3. fázis· Eli Lilly and Company· Forrás
Contact: Benjamin Garmezy (principal investigator)
Toboroz
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
NCT07136181· 1/2. fázis· Novelwise Pharmaceutical Corporation· Forrás
Contact: Annie Pai, PhD
Toboroz
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
NCT07192432· 1/2. fázis· Vironexis Biotherapeutics Inc.· Forrás
Contact: SCRI Referrals
Fut, nem toboroz
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121· 2/3. fázis· Bristol-Myers Squibb· Forrás
Toboroz
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
NCT07221500· 2. fázis· Nurix Therapeutics, Inc.· Forrás
Toboroz
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
NCT07106762· 2/3. fázis· Bristol-Myers Squibb· Forrás
Contact: Benjamin Garmezy, Site 0186
Toboroz
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
NCT07011576· 2. fázis· SCRI Development Innovations, LLC· Forrás
Contact: Sarah Cannon Sarah Cannon Development Innovations, LLC
Toboroz
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
NCT07090499· 1. fázis· Pfizer· Forrás
Toboroz
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
NCT06974786· 2. fázis· SCRI Development Innovations, LLC· Forrás
Contact: Hans Lee, MD (principal investigator)
Showing 50 of 133.